Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese RMS Patients Treated With Teriflunomide 14 mg Once Daily for 24 Weeks
- Status
- COMPLETED
- Phase
- PHASE4
First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL
- Status
- COMPLETED
- Phase
- PHASE1
The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma
- Status
- COMPLETED
- Phase
- PHASE4
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Status
- RECRUITING
- Phase
- N/A
Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC (CARMEN-LC04)
- Status
- TERMINATED
- Phase
- PHASE2
Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)
- Status
- COMPLETED
- Phase
- PHASE3
Anti-PD-1 Antibody Treatment With Cemiplimab and Radiotherapy in Early-stage Classical Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
Hydroxychloroquine in Outpatient Adults With COVID-19
- Status
- TERMINATED
- Phase
- PHASE1
Sarilumab COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone With Carfilzomib in Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Registry of Asthma Patients Initiating DUPIXENT®
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic Dermatitis
- Status
- COMPLETED
- Phase
- N/A
Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab Treatment
- Status
- RECRUITING
- Phase
- N/A
Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Trial of Hypofractionated IMRT Boost Versus Conventional IMRT Boost for Localized High Risk Prostate Cancer
- Status
- UNKNOWN
- Phase
- NA